PepTcell appoints Manfred Scheske as CEO of Consumer Health
PepTcell, a drug discovery group with an innovative mid- to late stage portfolio, announced the appointment of Manfred Scheske as Chief Executive Officer of Consumer Health.
Scheske, former President of Consumer Healthcare Europe at GlaxoSmithKline, is joining the Executive Team at PepTcell having enjoyed a highly successful 25-year career with GSK in Europe, North America and at a global level within GSK’s Consumer Healthcare Leadership Team.
Scheske, who was President of GSK’s £2 billion strong European Consumer Healthcare business from 2004 to 2010, also spent six years as President of GSK’s Consumer Healthcare business in North America. Amongst his successes was the launch of alli, GSK’s weight loss drug, which was the first pan-European switch from Rx to OTC. He built a market-leading position in the OTC smoking cessation market in the US and played a key role in the acquisition of Block Drug.
In his newly formed role at PepTcell, Scheske will have full responsibility for the consumer health portfolio. The leading products include a first-in-class cough suppressant with a clinically proven efficacy and safety profile. In addition, within the portfolio is a small molecule drug for inflammatory flare with a clinically proven safety analgesic profile entering Phase III trials.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.